Antifungal prophylaxis in hematopoietic stem cell transplant recipients

ONCOLOGY

Volumn 15, Issue 11 SUPPL. 9, 2001, Pages 15-19

  Marr, Kieren A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; CANDIDIASIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NEUTROPENIA; OPPORTUNISTIC INFECTION; REVIEW; RISK FACTOR;

AMPHOTERICIN B; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; FLUCONAZOLE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ITRACONAZOLE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 0035512370     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Marr KA, Seidel K, White TC, et al: Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 181:309-316, 2000.
2. Wald A, Leisenring W, van Burik JA, et al: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175:1459-1466, 1997.
3. Gallis HA, Drew RH, Pickard WW: Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12:308-329, 1990.
4. Rex J, Walsh T, Sobel J, et al: Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662-678, 2000.
5. Walsh T, Finberg R, Arndt C, et al: Liposomal amphotericin B for empiric therapy in patients with persistent fever and neutropenia. N Engl J Med 340(10):764-771, 1999.
6. Hansen JA, Gooley TA, Martin PJ, et al: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962-968, 1998.
7. Boeckh M, Gooley TA, Myerson D, et al: Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study. Blood 88:4063-4071, 1996.
8. Marr K, Seidel K, Slavin M, et al: Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial. Blood 96:2055-2061, 2000.
9. Goodman JL, Winston DJ, Greenfield RA, et al: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326(13):845-851, 1992.
10. Slavin MA, Osborne B, Adams R, et al: Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A prospective, randomized, double-blind study. J Infect Dis 171:1545-1552, 1995.
11. Schwartz S, Behre G, Heinemann V, et al: Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: Results of a prospective randomized multicenter trial. Blood 93:3654-3661, 1999.
12. Menichetti F, Del Favero A, Martino P, et al: Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind, multicenter trial. Clin Infect Dis 28:250-255, 1999.
13. Morgenstern OR, Prentice AG, Prentice HG, et al: A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 105:901-911, 1999.
14. Prentice HG, Hann IM, Herbrecht R, et al: A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 98:711-718, 1997.
15. Wingard JR, White MH, Anaissie EJ, et al: A randomized, double-blind safety study of AmBisome and Abelcet in febrile neutropenic patients (abstract 15). Program and abstracts from the Focus on Fungal Infections Conference, San Diego, March 17-19, 1999.
16. Leenders A, Daenen S, Ansen RJ, et al: Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infection. Br J Haematol 103(1):205-212, 1998.